Chimera Investment’s (CIM) Sector Perform Rating Reaffirmed at Royal Bank Of Canada

Royal Bank Of Canada restated their sector perform rating on shares of Chimera Investment (NYSE:CIMFree Report) in a research note released on Wednesday morning,Benzinga reports. Royal Bank Of Canada currently has a $14.00 price target on the real estate investment trust’s stock.

Other equities analysts have also issued research reports about the stock. Weiss Ratings lowered shares of Chimera Investment from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, May 20th. Wall Street Zen raised shares of Chimera Investment from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.83.

Check Out Our Latest Research Report on Chimera Investment

Chimera Investment Stock Down 2.9%

CIM opened at $13.15 on Wednesday. Chimera Investment has a fifty-two week low of $11.67 and a fifty-two week high of $14.88. The business has a 50-day moving average of $13.28 and a 200-day moving average of $13.05. The company has a debt-to-equity ratio of 2.31, a current ratio of 0.08 and a quick ratio of 0.08. The company has a market capitalization of $1.10 billion, a PE ratio of -16.44 and a beta of 1.68.

Chimera Investment (NYSE:CIMGet Free Report) last posted its quarterly earnings results on Thursday, May 7th. The real estate investment trust reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.02. The company had revenue of $32.37 million during the quarter, compared to the consensus estimate of $102.35 million. Chimera Investment had a return on equity of 9.36% and a net margin of 2.27%.

Hedge Funds Weigh In On Chimera Investment

A number of institutional investors have recently modified their holdings of CIM. SG Americas Securities LLC bought a new position in shares of Chimera Investment in the fourth quarter valued at approximately $7,431,000. UBS Group AG raised its position in shares of Chimera Investment by 130.7% in the fourth quarter. UBS Group AG now owns 763,691 shares of the real estate investment trust’s stock valued at $9,493,000 after purchasing an additional 432,727 shares during the period. Ritholtz Wealth Management bought a new position in shares of Chimera Investment in the fourth quarter valued at approximately $4,977,000. Allianz Asset Management GmbH raised its position in shares of Chimera Investment by 21.7% in the third quarter. Allianz Asset Management GmbH now owns 1,671,318 shares of the real estate investment trust’s stock valued at $22,095,000 after purchasing an additional 297,709 shares during the period. Finally, Millennium Management LLC raised its position in shares of Chimera Investment by 65.8% in the fourth quarter. Millennium Management LLC now owns 697,620 shares of the real estate investment trust’s stock valued at $8,671,000 after purchasing an additional 276,950 shares during the period. Institutional investors own 48.44% of the company’s stock.

Chimera Investment Company Profile

(Get Free Report)

Chimera Investment Corporation (NYSE: CIM) is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company’s portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.

The firm’s core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.

See Also

Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.